Bioray Laboratories clinical trial pipeline

3 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 3 with minor changes only.

1. Minor

   3 trials marked Unknown by the registry's verification sweep

   1. Minor

      Universal CAR-T Cell Therapy for Refractory Lupus Nephritis

      Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting

      Bioray Laboratories·Early Phase 1· NCT06681337· Registry history of NCT06681337 on ClinicalTrials.gov (opens the registry)

      Changed Oct 4, 2026

   2. Minor

      Universal CAR-T Cells Targeting BCMA · Refractory NMOSD

      Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting

      Bioray Laboratories·Phase 1· NCT06633042· Registry history of NCT06633042 on ClinicalTrials.gov (opens the registry)

      Changed Oct 4, 2026

   3. Minor

      Universal CAR-T Cells (BRL-301) in Refractory Systemic Lupus…Universal CAR-T Cells (BRL-301) in Refractory Systemic Lupus Erythematosus

      Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting

      Bioray Laboratories·Not applicable· NCT05988216· Registry history of NCT05988216 on ClinicalTrials.gov (opens the registry)

      Changed Oct 4, 2026

   Registry verification sweep

   Changed Oct 4, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.